ТОР10 Rx drug launches in the out-of-pocket segment of Russia’s pharma market by sales, 2013*

Rank

ТМ

Corporation

2nd level АТС group

Sales (mn RUB)

1

Proflosin

Berlin-Chemie / Menarini

04 — Urologicals

36.26

2

Suprax Solutab

Astellas Pharma

J01 — Systemic antibacterials

32.86

3

Tornetis

Sandoz Group / Novartis

G04 — Urologicals

30.20

4

Esmy

Gedeon Richter

G03 — Sex hormones and products with similar desired effects, systemic action only

22.53

5

Ontime

Teva

A02 — Antacids, antiflatulents and anti-ulcerants

19.95

6

Algeron

Biocad

L03 — Immunostimulating agents

16.13

7

Carvedilol Zentiva

Zentiva

C07 — Beta-blocking agents

15.80

8

Concor AM

Takeda

C07 — Beta-blocking agents

13.41

9

Rapimed

Actavis

N02 — Analgesics

12.45

10

 Amzaar

Merck Sharp & Dohme

C09 — Agents acting on the reninangiotensin system

13.37